Sortera bio
Pre-clinicalSortera's game changing approach to drug discovery sets the standard for the future of biologics. Deep Screening, our breakthrough technology, generates massive sequence-function datasets that power AI models, giving us unmatched speed and control over the discovery process.
Founded
2021
Focus
AI / Machine LearningBiologics
About
Sortera's game changing approach to drug discovery sets the standard for the future of biologics. Deep Screening, our breakthrough technology, generates massive sequence-function datasets that power AI models, giving us unmatched speed and control over the discovery process.
Funding History
2Total raised: $18.5M
Series A$15MNorthpond VenturesNov 15, 2022
Seed$3.5MAhren Innovation CapitalMar 15, 2021
Company Info
TypePrivate
Founded2021
LocationLondon, United Kingdom
StagePre-clinical
Contact
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile